{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T14:42:46Z","timestamp":1780065766360,"version":"3.54.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,14]],"date-time":"2020-03-14T00:00:00Z","timestamp":1584144000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,14]],"date-time":"2020-03-14T00:00:00Z","timestamp":1584144000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000380","name":"Guys and St Thomas' Charity","doi-asserted-by":"crossref","award":["MAJ140701"],"award-info":[{"award-number":["MAJ140701"]}],"id":[{"id":"10.13039\/501100000380","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Alcohol-related hospital admissions have doubled in the last ten years to &gt;\u20091.2\u2009m per year in England. High-need, high-cost (HNHC) alcohol-related frequent attenders (ARFA) are a relatively small subgroup of patients, having multiple admissions or attendances from alcohol during a short time period. This trial aims to test the effectiveness of an assertive outreach treatment (AOT) approach in improving clinical outcomes for ARFA, and reducing resource use in the acute setting.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>One hundred and\u00a0sixty ARFA patients will be recruited and following baseline assessment, randomly assigned to AOT plus care as usual (CAU) or CAU alone in equal numbers. Baseline assessment includes alcohol consumption and related problems, physical and mental health comorbidity and health and social care service use in the previous 6 months using standard validated tools, plus a measure of resource use. Follow-up assessments at 6 and 12\u2009months after randomization includes the same tools as baseline plus standard measure of patient satisfaction. Outcomes for CAU\u2009+\u2009AOT and CAU at 6 and 12\u2009months will be compared, controlling for pre-specified baseline measures. Primary outcome will be percentage of days abstinent at 12\u2009months. Secondary outcomes include emergency department (ED) attendance, number and length of hospital admissions, alcohol consumption, alcohol-related problems, other health service use, mental and physical comorbidity 6 and 12\u2009months post intervention. Health economic analysis will estimate the economic impact of AOT from health, social care and societal perspectives and explore cost-effectiveness in terms of quality adjusted life years and alcohol consumption at 12-month follow-up.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>AOT models piloted with alcohol dependent patients have demonstrated significant reductions in alcohol consumption and use of unplanned National Health Service (NHS) care, with increased engagement with alcohol treatment services, compared with patients receiving CAU. While AOT interventions are costlier per case than current standard care in the UK, the rationale for targeting HNHC ARFAs is because of their disproportionate contribution to overall alcohol burden on the NHS. No previous studies have evaluated the clinical and cost-effectiveness of AOT for HNHC ARFAs: this randomized controlled trial (RCT) targeting ARFAs across five South London NHS Trusts is the first.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration<\/jats:title><jats:p>International standard randomized controlled trial number (ISRCTN) registry:<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/doi.org\/10.1186\/ISRCTN67000214\">ISRCTN67000214<\/jats:ext-link>, retrospectively registered 26\/11\/2016.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12889-020-8437-y","type":"journal-article","created":{"date-parts":[[2020,3,14]],"date-time":"2020-03-14T11:03:20Z","timestamp":1584183800000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Assertive outreach treatment versus care as usual for the treatment of high-need, high-cost alcohol related frequent attenders: study protocol for a randomised controlled trial"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9284-0810","authenticated-orcid":false,"given":"R.","family":"Blackwood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Wolstenholme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kimerg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Fincham-Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Khadjesari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Coulton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Byford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Deluca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Currell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"O\u2019Toole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Winnington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Finch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Drummond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,14]]},"reference":[{"key":"8437_CR1","unstructured":"Collaborators for GBD. Alcohol use and burden for 195 countries and territories, 1990\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet. 2018:392:1015\u201332."},{"key":"8437_CR2","doi-asserted-by":"crossref","unstructured":"Rehm, et al. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet. 2009:373:2223\u201333.","DOI":"10.1016\/S0140-6736(09)60746-7"},{"key":"8437_CR3","doi-asserted-by":"crossref","unstructured":"Shield, et al. Societal burden of alcohol. In: Anderson P, Moller L, Galea G, editors. Alcohol in the European Union. Consumption, harm and policy approaches. Copenhagen: World Health Organization Regional Office for Europe; 2012. p. 10\u201328.","DOI":"10.1186\/1478-7954-10-9"},{"key":"8437_CR4","unstructured":"Lim, et al. The burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions 1990\u20132010: a systematic analysis. Lancet. 2012:380:2224\u201360."},{"key":"8437_CR5","unstructured":"Currie, et al. Alcohol-specific activity in hospitals in England, Nuffield trust; 2015."},{"key":"8437_CR6","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/S0140-6736(17)32866-0","volume":"391","author":"Williams","year":"2018","unstructured":"Williams, et al. Disease burden and costs from excess alcohol consumption, obesity and viral hepatitis: 4th report of the lancet standing commission on liver disease in the UK. Lancet. 2018;391:1097\u2013107.","journal-title":"Lancet"},{"key":"8437_CR7","volume-title":"Public health responsibility Deal","author":"Department of Health","year":"2013","unstructured":"Department of Health. Public health responsibility Deal; 2013. Available at: https:\/\/responsibilitydeal.dh.gov.uk\/wp-content\/uploads\/2013\/02\/Generic-RD-Flyer-Final.pdf."},{"key":"8437_CR8","volume-title":"\u2018The Government\u2019s alcohol strategy\u2019, HM government","author":"Secretary of State for the Home Department","year":"2012","unstructured":"Secretary of State for the Home Department. \u2018The Government\u2019s alcohol strategy\u2019, HM government; 2012."},{"key":"8437_CR9","volume-title":"Statistics on alcohol in England 2017","author":"NHS Digital","year":"2017","unstructured":"NHS Digital. Statistics on alcohol in England 2017; 2017. NHS Digital."},{"key":"8437_CR10","volume-title":"Public health outcomes framework","author":"Public Health England","year":"2014","unstructured":"Public Health England. Public health outcomes framework; 2014. https:\/\/www.gov.uk\/government\/collections\/public-health-outcomes-framework."},{"issue":"1","key":"8437_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/09687637.2016.1185091","volume":"24","author":"J Neale","year":"2017","unstructured":"Neale J, Parkman T, Day E, Drummond C. Socio-demographic characteristics and stereotyping of people who frequently attend accident and emergency departments for alcohol-related reasons: qualitative study. Drugs Educ Prev Policy. 2017;24(1):67\u201374.","journal-title":"Drugs Educ Prev Policy"},{"issue":"2","key":"8437_CR12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/alcalc\/agq089","volume":"46","author":"Schomerus","year":"2011","unstructured":"Schomerus, et al. The stigma of alcohol dependence compared with other mental disorders: a review of population studies. Alcohol Alcohol. 2011;46(2):105\u201312.","journal-title":"Alcohol Alcohol"},{"issue":"4","key":"8437_CR13","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1093\/alcalc\/agn025","volume":"43","author":"F Passetti","year":"2008","unstructured":"Passetti F, Jones G, Chawla K, Boland B, Drummond C. Pilot study of assertive community treatment methods to engage alcohol-dependent individuals. Alcohol Alcohol. 2008;43(4):451\u20135.","journal-title":"Alcohol Alcohol"},{"issue":"1","key":"8437_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1745-6215-13-19","volume":"13","author":"H Gilburt","year":"2012","unstructured":"Gilburt H, Burns T, Copello A, Coulton S, Crawford M, Day E, et al. Assertive community treatment for alcohol dependence (ACTAD): study protocol for a randomised controlled trial. Trials. 2012;13(1):19.","journal-title":"Trials"},{"key":"8437_CR15","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1136\/flgastro-2012-100260","volume":"4","author":"NR Hughes","year":"2013","unstructured":"Hughes NR, Houghton N, Nadeem H, Bell J, McDonald S, Glynn N, et al. Salford alcohol assertive outreach team: a new model for reducing alcohol-related admissions. Frontline Gastroenterol. 2013;4:130\u20134.","journal-title":"Frontline Gastroenterol"},{"key":"8437_CR16","volume-title":"Alcohol care teams: reducing acute hospital admissions and improving quality of care. Quality and productivity proven case study","author":"NHS Evidence","year":"2014","unstructured":"NHS Evidence. Alcohol care teams: reducing acute hospital admissions and improving quality of care. Quality and productivity proven case study; 2014. https:\/\/www.evidence.nhs.uk\/topic\/alcohol?om=%5B%7B%22srn%22%3A%5B%22%20qipp%20%22%5D%7D%5D."},{"key":"8437_CR17","volume-title":"Alcohol care teams in England\u2019s hospitals: an opportunity not to be missed","author":"Public Health England","year":"2014","unstructured":"Public Health England. Alcohol care teams in England\u2019s hospitals: an opportunity not to be missed. London: PHE; 2014."},{"key":"8437_CR18","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/j.1530-0277.2001.tb02137.x","volume":"25","author":"ME Hilton","year":"2001","unstructured":"Hilton ME, Maisto SA, Conigliaro J, et al. Improving alcoholism treatment across the spectrum of services. Alcohol Clin Exp Res. 2001;25:128\u201335.","journal-title":"Alcohol Clin Exp Res"},{"key":"8437_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0306-4603(98)00029-X","volume":"24","author":"RL Stout","year":"1999","unstructured":"Stout RL, Rubin A, Zwick W, et al. Optimizing the cost- effectiveness of alcohol treatment: a rationale for extended case monitoring. Addict Behav. 1999;24:17\u201335.","journal-title":"Addict Behav"},{"key":"8437_CR20","volume-title":"Review of 70 years of international longitudinal research","author":"KM Fillmore","year":"1988","unstructured":"Fillmore KM. Alcohol review across the life course. In: Review of 70 years of international longitudinal research. Toronto: Addiction Research Foundation; 1988."},{"issue":"3","key":"8437_CR21","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1093\/alcalc\/agx095","volume":"53","author":"S Fincham-Campbell","year":"2018","unstructured":"Fincham-Campbell S, Kimerg\u00e5rd A, Wolstenholme A, Blackwood R, Patton R, Dunne J, et al. A national survey of assertive outreach treatment services for people who frequently attend hospital due to alcohol-related reasons in England. Alcohol Alcohol. 2018;53(3):277\u201381.","journal-title":"Alcohol Alcohol"},{"key":"8437_CR22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189\u201398.","journal-title":"J Psychiatr Res"},{"key":"8437_CR23","volume-title":"Form 90: a structured assessment interview for drinking and related behaviours project MATCH monograph 5","author":"WR Miller","year":"1995","unstructured":"Miller WR. Form 90: a structured assessment interview for drinking and related behaviours project MATCH monograph 5. Rockville: National Institute on Alcohol Abuse and Alcoholism; 1995."},{"key":"8437_CR24","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/j.1360-0443.1990.tb00652.x","volume":"85","author":"C Drummond","year":"1990","unstructured":"Drummond C. The relationship between alcohol dependence and alcohol related problems in a clinical population. Br J Addict. 1990;85:357\u201366.","journal-title":"Br J Addict"},{"key":"8437_CR25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1360-0443.1983.tb02503.x","volume":"78","author":"T Stockwell","year":"1983","unstructured":"Stockwell T, Murphy D, Hodgson R. The severity of alcohol dependence questionnaire: its use, reliability and validity. Br J Addict. 1983;78:45\u2013156.","journal-title":"Br J Addict"},{"key":"8437_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"The EuroQol Group","year":"1990","unstructured":"The EuroQol Group. EuroQol: a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199\u2013208.","journal-title":"Health Policy"},{"issue":"7","key":"8437_CR27","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s11136-012-0322-4","volume":"22","author":"MF Janssen","year":"2013","unstructured":"Janssen MF, Pickard AS, Golicki D, Gudex C, Niewada M, Scalone L, et al. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res. 2013;22(7):1717\u201327.","journal-title":"Qual Life Res"},{"key":"8437_CR28","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","volume":"34","author":"JE Ware Jr","year":"1996","unstructured":"Ware JE Jr, Kosinski M, Keller SD. A 12 item short form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220\u201333.","journal-title":"Med Care"},{"key":"8437_CR29","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3109\/16066359909004375","volume":"7","author":"N Heather","year":"1999","unstructured":"Heather N, Luce A, Peck D, Dunbar B, James I. The development of a treatment version of the readiness to change questionnaire. Addict Res Theory. 1999;7:63\u20138.","journal-title":"Addict Res Theory"},{"key":"8437_CR30","unstructured":"Clifford PR, Longabaugh R: Manual for the administration of the Important People and Activities Instrument 1991, Adapted for use by project MATCH for NIAAA 5R01AA06698\u201305 environmental treatment of alcohol abusers, Richard Longabaugh, Principal Investigator; 1991."},{"issue":"1","key":"8437_CR31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.drugalcdep.2005.05.015","volume":"81","author":"B Barrett","year":"2006","unstructured":"Barrett B, Byford S, Crawford MJ, Patton R, Drummond C, Henry JA, et al. Cost-effectiveness of screening and referral to an alcohol health worker in alcohol misusing patients attending an accident and emergency department: a decision-making approach. Drug Alcohol Depend. 2006;81(1):47\u201354.","journal-title":"Drug Alcohol Depend"},{"key":"8437_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1017\/S0033291706009299","volume":"37","author":"R McGuire-Snieckus","year":"2007","unstructured":"McGuire-Snieckus R, McCabe R, Catty J, Hansson L, Priebe S. A new scale to assess the therapeutic relationship in community mental health care: STAR. Psychol Med. 2007;37:85\u201395.","journal-title":"Psychol Med"},{"issue":"7516","key":"8437_CR33","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1136\/bmj.331.7516.544","volume":"331","author":"Godfrey","year":"2005","unstructured":"Godfrey, et al. Cost effectiveness of treatment for alcohol problems: findings of the UK alcohol treatment trial (UKATT). BMJ. 2005;331(7516):544\u20138.","journal-title":"BMJ"},{"key":"8437_CR34","volume-title":"Guide to the methods of technology appraisal","author":"National Institute for Health and Clinical Excellence","year":"2013","unstructured":"National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal. London: National Institute for Health and Clinical Excellence; 2013."},{"key":"8437_CR35","doi-asserted-by":"publisher","DOI":"10.22024\/UniKent\/01.02\/65559","volume-title":"Unit costs of health and social care 2017, personal social services research unit","author":"L Curtis","year":"2017","unstructured":"Curtis L, Burns A. Unit costs of health and social care 2017, personal social services research unit. Canterbury: University of Kent; 2017. https:\/\/doi.org\/10.22024\/UniKent\/01.02\/65559."},{"key":"8437_CR36","volume-title":"The economic and social costs of crime against individuals and households 2003\/04","author":"R Dubourg","year":"2005","unstructured":"Dubourg R, Hamed J, Thorns J. The economic and social costs of crime against individuals and households 2003\/04. London: The Home Office; 2005."},{"key":"8437_CR37","doi-asserted-by":"publisher","first-page":"460","DOI":"10.2165\/00019053-199610050-00003","volume":"10","author":"M Koopmanschap","year":"1996","unstructured":"Koopmanschap M, Rutten F. A practical guide for calculating indirect costs of disease. Pharmacoeconomics. 1996;10:460\u20136.","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"8437_CR38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/hec.3560","volume":"27","author":"Y Feng","year":"2018","unstructured":"Feng Y, Devlin N, Shah K, Mulhern B, van Hout B. New methods for modelling EQ-5D-5L value sets: an application to English data. Health Econ. 2018;27(1):23\u201338.","journal-title":"Health Econ"},{"issue":"12","key":"8437_CR39","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/hec.901","volume":"13","author":"G Richardson","year":"2004","unstructured":"Richardson G, Manca A. Calculation of quality adjusted life years in the published literature: a review of methodology and transparency. Health Econ. 2004;13(12):1203\u201310.","journal-title":"Health Econ"},{"key":"8437_CR40","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/hec.4730030505","volume":"3","author":"BA Van Hout","year":"1994","unstructured":"Van Hout BA, Al MJ, Gordon GS, Rutten FFH. Costs, effects and c\/e-ratios alongside a clinical trial. Health Econ. 1994;3:309\u201319.","journal-title":"Health Econ"},{"key":"8437_CR41","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/hec.635","volume":"10","author":"E Fenwick","year":"2001","unstructured":"Fenwick E, Claxton K, Sculpher M. Representing uncertainty : the role of cost-effectiveness acceptability curves. Health Econ. 2001;10:779\u201387.","journal-title":"Health Econ"},{"key":"8437_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-4541-9","volume-title":"An introduction to the bootstrap","author":"B Efron","year":"1993","unstructured":"Efron B, Tibshirani RJ. An introduction to the bootstrap. New York: Chapman & Hall; 1993."},{"key":"8437_CR43","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1136\/bmj.317.7167.1195","volume":"317","author":"JA Barber","year":"1998","unstructured":"Barber JA, Thompson SG. Analysis and interpretation of cost data in randomised control trials : review of published studies. Br Med J. 1998;317:1195\u20132000.","journal-title":"Br Med J"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-020-8437-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12889-020-8437-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-020-8437-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T20:50:53Z","timestamp":1666126253000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-020-8437-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,14]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["8437"],"URL":"https:\/\/doi.org\/10.1186\/s12889-020-8437-y","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,14]]},"assertion":[{"value":"18 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval: 06 April 2016: London - Harrow Research Ethics Committee. REC reference: 16\/LO\/0411. HRA approval: 06 July 2016: HRA. IRAS project ID: 191704. All study participants will provide written consent to participate: participants will be asked to complete and sign an electronic consent form on an iPad.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable as no details of individuals reported within the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"332"}}